Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMUX | AMGN | REGN | VRTX | GILD |
| Company | Immunic Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.5500 | 316.66 | 1,007.46 | 460.00 | 85.18 |
| High | 1.5600 | 320.92 | 1,013.41 | 464.52 | 86.85 |
| Low | 1.4900 | 314.70 | 1,001.00 | 456.16 | 85.06 |
| Last | 1.4950 | 320.49 | 1,013.46 | 464.94 | 86.06 |
| Change | -0.0650 | +2.81 | +8.20 | +6.00 | +0.85 |
| % Change | -4.17% | +0.88% | +0.82% | +1.31% | +1.00% |
| Volume | 295,408 | 681,398 | 288,390 | 365,657 | 3,542,323 |
| 20-Day Average Volume | 592,998 | 2,024,531 | 700,514 | 973,135 | 7,418,773 |
| Previous Close | 1.5600 | 317.68 | 1,005.26 | 458.94 | 85.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6072 | 325.64 | 1,073.97 | 467.00 | 83.90 |
| 20-Day Raw Stochastic | 9.85% | 29.88% | 9.00% | 38.85% | 95.73% |
| 20-Day Relative Strength | 49.55% | 46.22% | 33.40% | 47.19% | 71.98% |
| Weighted Alpha | +12.55 | +13.33 | +14.98 | +22.04 | +19.97 |
| Today's Opinion | 88% Buy | 24% Buy | 8% Sell | 8% Sell | 100% Buy |
| Previous Opinion | 88% Buy | 24% Buy | 8% Sell | 8% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 80% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.72% since 10/02/24 | +0.16% since 10/02/24 | -3.03% since 10/02/24 | +0.44% since 10/02/24 | +2.22% since 10/02/24 |
| Low | 1.5000 on 10/09/24 | 314.70 on 10/09/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 83.98 on 10/04/24 |
| High | 1.6400 on 10/03/24 | 320.92 on 10/09/24 | 1,038.81 on 10/03/24 | 464.52 on 10/09/24 | 86.85 on 10/09/24 |
| 1-Month | |||||
| %Chg | +8.21% since 09/09/24 | -1.75% since 09/09/24 | -11.88% since 09/09/24 | -1.47% since 09/09/24 | +9.41% since 09/09/24 |
| Low | 1.4000 on 09/10/24 | 312.16 on 09/25/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 78.73 on 09/10/24 |
| High | 2.1100 on 09/19/24 | 339.17 on 09/23/24 | 1,170.58 on 09/13/24 | 490.15 on 09/16/24 | 86.85 on 10/09/24 |
| 3-Month | |||||
| %Chg | +21.20% since 07/09/24 | +1.37% since 07/09/24 | -4.29% since 07/09/24 | -4.49% since 07/09/24 | +27.83% since 07/09/24 |
| Low | 1.1000 on 08/08/24 | 306.59 on 08/07/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 67.65 on 07/10/24 |
| High | 2.1100 on 09/19/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| 6-Month | |||||
| %Chg | +17.44% since 04/09/24 | +18.45% since 04/09/24 | +6.88% since 04/09/24 | +14.76% since 04/09/24 | +23.85% since 04/09/24 |
| Low | 0.9700 on 06/26/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 2.1100 on 09/19/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 140,523 | 170,414,656 | 110,765,568 | 118,430,848 | 106,159,136 |
| Shares Outstanding, K | 90,079 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -93,610,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | -21,380,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 1.84 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/08/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.07 | 25.93 | 0.00 | 17.96 |